Cargando…

Global Vaccine Hesitancy Segmentation: A Cross-European Approach

Vaccine-preventable diseases are global mainly in a globalized world that is characterized by a continuous movement of people and goods across countries. Vaccine hesitancy, the reluctance or refusal to vaccinate despite the availability of vaccines, is rising worldwide. What if the problem of vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Recio-Román, Almudena, Recio-Menéndez, Manuel, Román-González, María Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227608/
https://www.ncbi.nlm.nih.gov/pubmed/34201130
http://dx.doi.org/10.3390/vaccines9060617
_version_ 1783712562651594752
author Recio-Román, Almudena
Recio-Menéndez, Manuel
Román-González, María Victoria
author_facet Recio-Román, Almudena
Recio-Menéndez, Manuel
Román-González, María Victoria
author_sort Recio-Román, Almudena
collection PubMed
description Vaccine-preventable diseases are global mainly in a globalized world that is characterized by a continuous movement of people and goods across countries. Vaccine hesitancy, the reluctance or refusal to vaccinate despite the availability of vaccines, is rising worldwide. What if the problem of vaccine hesitancy could be most effectively managed when treated globally rather than on a national or regional basis? What if a global vaccine-hesitant segment exists and the differences among countries are not so significant? Based on the Global Marketing Strategy paradigm, this paper shows that seven different cross-European segments exist based on the beliefs, attitudes, and behaviors collected in 28 European countries. These pan-European segments are differentiable (people in those segments have similar characteristics that are visibly dissimilar from the ones in other segments) and actionable (organizations would be able to propose interventions to the hesitant segments based on their profiles). With segmentation being the starting point of many public health intervention strategies for avoiding vaccine-hesitancy, the results recommend moderating the full-adaptation strategy that follows the “context matters” principle suggested by several political and public health international organizations. Embracing a more standardized strategy will allow the development of better services and strategies that support and enable desirable vaccination behaviors.
format Online
Article
Text
id pubmed-8227608
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82276082021-06-26 Global Vaccine Hesitancy Segmentation: A Cross-European Approach Recio-Román, Almudena Recio-Menéndez, Manuel Román-González, María Victoria Vaccines (Basel) Article Vaccine-preventable diseases are global mainly in a globalized world that is characterized by a continuous movement of people and goods across countries. Vaccine hesitancy, the reluctance or refusal to vaccinate despite the availability of vaccines, is rising worldwide. What if the problem of vaccine hesitancy could be most effectively managed when treated globally rather than on a national or regional basis? What if a global vaccine-hesitant segment exists and the differences among countries are not so significant? Based on the Global Marketing Strategy paradigm, this paper shows that seven different cross-European segments exist based on the beliefs, attitudes, and behaviors collected in 28 European countries. These pan-European segments are differentiable (people in those segments have similar characteristics that are visibly dissimilar from the ones in other segments) and actionable (organizations would be able to propose interventions to the hesitant segments based on their profiles). With segmentation being the starting point of many public health intervention strategies for avoiding vaccine-hesitancy, the results recommend moderating the full-adaptation strategy that follows the “context matters” principle suggested by several political and public health international organizations. Embracing a more standardized strategy will allow the development of better services and strategies that support and enable desirable vaccination behaviors. MDPI 2021-06-08 /pmc/articles/PMC8227608/ /pubmed/34201130 http://dx.doi.org/10.3390/vaccines9060617 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Recio-Román, Almudena
Recio-Menéndez, Manuel
Román-González, María Victoria
Global Vaccine Hesitancy Segmentation: A Cross-European Approach
title Global Vaccine Hesitancy Segmentation: A Cross-European Approach
title_full Global Vaccine Hesitancy Segmentation: A Cross-European Approach
title_fullStr Global Vaccine Hesitancy Segmentation: A Cross-European Approach
title_full_unstemmed Global Vaccine Hesitancy Segmentation: A Cross-European Approach
title_short Global Vaccine Hesitancy Segmentation: A Cross-European Approach
title_sort global vaccine hesitancy segmentation: a cross-european approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227608/
https://www.ncbi.nlm.nih.gov/pubmed/34201130
http://dx.doi.org/10.3390/vaccines9060617
work_keys_str_mv AT recioromanalmudena globalvaccinehesitancysegmentationacrosseuropeanapproach
AT reciomenendezmanuel globalvaccinehesitancysegmentationacrosseuropeanapproach
AT romangonzalezmariavictoria globalvaccinehesitancysegmentationacrosseuropeanapproach